West Virginia considering making PSE prescription-only
CHARLESTON, W.Va. — West Virginia took one step closer to making pseudoephedrine products prescription-only, as the state’s Senate Committee on Health voted Tuesday to move ahead with the proposal, according to an Associated Press report.
According to the report, the bill would allow an exception for certain over-the-counter drugs that are deemed "tamper resistant" by the Board of Pharmacy.
The measure is opposed by the West Virginia Retailers Association.
Inergetics to develop line of Cannibidiol based nutritional supplements
NEWARK, N.J. — Inergetics on Tuesday announced it has entered into a strategic partnership with Terra Tech Corp, a fast-growing urban agricultural company, to jointly develop a line of natural cannibidiol-based nutritional supplements.
The strategic partnership will combine Inergetics’ expertise in successfully developing and marketing innovative nutritional supplements that help consumers lead better and healthier lives with Terra Tech’s agricultural expertise and established distribution network of dispensaries in medical cannabis markets.
The featured active ingredient in this new product line will be cannibidiol, a non-psychoactive component of cannabis that possesses a wide range of therapeutic benefits. The supplements will be initially marketed to consumers of medical cannabis in legally approved markets who suffer from nausea and/or such illnesses as glaucoma, and who can benefit from CBD’s pain management and other therapeutic properties. To date, 20 states and the District of Columbia have enacted laws to legalize medical marijuana.
"We’re pleased to be entering into this strategic partnership with Terra Tech, and we look forward to developing a unique supplement line to help patients manage their pain," stated Inergetics CEO Mike James. "This partnership will help Inergetics expand our product line into pain management supplements for consumers who are looking to address these symptoms while improving their quality of life."
GSK, Walgreens launch Sponsorship to Quit, a free online quit-smoking program
PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare and Walgreens on Wednesday teamed up to launch Sponsorship to Quit, a free online quit-smoking program that smokers can personalize with customized tools and tips during their journey to quit.
After completing an online consultation, a smoker can access tools that help track successes and slip ups, earn badges, celebrate milestones and access expert information and tips 24/7. Smokers receive a tailored quit plan that offers help in selecting the right nicotine-replacement therapy and a form and strength that best matches their needs, like nicotine gum, lozenges or patches. Smokers can sign up to receive a free quit kit upon registration, a quit journal and an official quitter card, a physical reminder of smokers’ commitment to quit.
To help encourage a healthier lifestyle, Sponsorship to Quit is asking America to take to social media and share their top reason for quitting smoking in 2014, using the hashtag #STQuit. Walgreens and GSK will reveal the top 10 responses in February. The No. 1 “quitspiration” will inspire a $10,000 donation to a related Walgreens and GSK-selected charity.
“People are frequently reminded of the benefits related to quitting smoking, but adopting healthier habits can be challenging. Highlighting the positive and happy moments that can result from quitting could be that extra motivation needed to pursue a smoke-free lifestyle,” stated Robert Tompkins, group VP and general merchandising manager for health and wellness at Walgreens. “We hope #STQuit inspires people to make a difference in their lives, and Sponsorship to Quit encourages results with a tailored plan that provides support and motivation throughout the quit journey.”
For more information about Sponsorship to Quit and to download a free quit kit, visit SponsorshiptoQuit.com.